Clinical and biochemical profile of patients with “pure” uric acid nephrolithiasis compared with “pure” calcium oxalate stone formers

Armando Negri(Universidad del Salvador), José Zanchetta(Universidad del Salvador), Irene Pinduli(Universidad del Salvador), Elisa Del Valle(Universidad del Salvador), Alicia Marino(Instituto de Diagnóstico e Investigaciones Metabólicas), Rodolfo Spivacow(Universidad del Salvador), Erich Fradinger(Universidad del Salvador)
Urological Research
September 4, 2007
10.1007/s00240-007-0109-1
Cited by 44

Related Papers

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2001|4.6k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.5k
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
|New England Journal of Medicine|2014|1.2k
Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial
|Journal of Bone and Mineral Research|2008|508
Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial
|Arthritis & Rheumatism|2009|497